June 2024

New CRISPR Screening Platform Could Drive Development of Next-Generation Drugs

Scientists at the Frederick National Laboratory for Cancer Research and their National Cancer Institute colleagues have developed a method that enhances the capacity to identify interactions between proteins and molecules that are critical to drug targeting. The study, reported in Science Advances, includes libraries to aid other researchers.